Cargando…
A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry
Background: Growing evidence has confirmed that populations with type 2 diabetes mellitus (T2DM) have an increasing risk of developing colorectal cancer (CRC). Thus, convenient and effective screening strategies for CRC should be developed for the T2DM population to increase the detection rate of CR...
Autores principales: | Yang, Jiayue, Fang, Weigang, Wu, Wenjun, Tian, Zhen, Gao, Rong, Yu, Lu, Chen, Dayang, Weng, Xiaohua, Zhu, Shengwei, Yang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670180/ https://www.ncbi.nlm.nih.gov/pubmed/34917649 http://dx.doi.org/10.3389/fmolb.2021.736272 |
Ejemplares similares
-
Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients
por: Yang, Jiayue, et al.
Publicado: (2021) -
Mass Spectrometry-Based Targeted Serum Monomethylated Ribonucleosides Profiling for Early Detection of Breast Cancer
por: Fang, Zhihao, et al.
Publicado: (2021) -
Profiling Urinary Sulfate Metabolites With Mass Spectrometry
por: Fitzgerald, Christopher C. J., et al.
Publicado: (2022) -
Integrating the potential of ion mobility spectrometry-mass spectrometry in the separation and structural characterisation of lipid isomers
por: Camunas-Alberca, Sandra M., et al.
Publicado: (2023) -
MALDI-TOF Mass Spectrometry for interrogating ubiquitin enzymes
por: De Cesare, Virginia
Publicado: (2023)